Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S.
Dexcom (DXCM) is down more than -6% after it said it received a warning letter from the FDA following inspections of its facilities in San Diego, California and Messa, Arizona. Emerson Electric (EMR) ...